Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion
Open Access
- 24 June 2019
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-12
Abstract
We investigated whether or to what extent the interaction of lipoprotein (a) [Lp(a)] with cholesterol-containing lipids was associated with angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion. Serum levels of Lp(a), total cholesterol, low-density lipoprotein–cholesterol (LDL-C), high-density lipoprotein–cholesterol (HDL-C), and triglyceride were determined and non-HDL-C was calculated in 706 type 2 diabetic and 578 non-diabetic patients with stable coronary artery disease and angiographic total occlusion of at least one major coronary artery. The degree of collaterals supplying the distal aspect of a total occlusion from the contra-lateral vessel was graded as poor (Rentrop score of 0 or 1) or good coronary collateralization (Rentrop score of 2 or 3). For diabetic and non-diabetic patients, Lp(a), total cholesterol, LDL-C, and non-HDL-C levels were higher in patients with poor coronary collateralization than in those with good collateralization, whereas HDL-C and triglyceride levels were similar. After adjustment for potential confounding factors, tertiles of Lp(a), total cholesterol, LDL-C and non-HDL-C remained independent determinants for poor collateralization. A significant interaction between Lp(a) and total cholesterol, LDL-C or non-HDL-C was observed in diabetic patients (all P interaction < 0.001) but not in non-diabetics. At high tertile of total cholesterol (≥ 5.35 mmol/L), LDL-C (≥ 3.36 mmol/L) and non-HDL-C (≥ 4.38 mmol/L), diabetic patients with high tertile of Lp(a) (≥ 30.23 mg/dL) had an increased risk of poor collateralization compared with those with low tertile of Lp(a) (< 12.66 mg/dL) (adjusted OR = 4.300, 3.970 and 4.386, respectively, all P < 0.001). Increased Lp(a) confers greater risk for poor coronary collateralization when total cholesterol, LDL-C or non-HDL-C are elevated especially for patients with type 2 diabetes.Keywords
Funding Information
- the Research Foundation of Chinese National Natural Science (81670451, 81770437, 81770447)
- Shanghai Science & Technology Committee (14ZR1425800)
- Medico-engineering Project (GY2016MS66)
- Talent Young Investigators of Shanghai Jiao Tong University School of Medicine (17XJ11009)
- Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20181801)
This publication has 61 references indexed in Scilit:
- The human coronary collateral circulation: development and clinical importanceEuropean Heart Journal, 2013
- Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery diseaseBMC Research Notes, 2013
- Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusionCardiovascular Diabetology, 2013
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable AnginaJACC, 2007
- Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohortJACC, 2004
- Impairment of Collateral Formation in Lipoprotein(a) Transgenic MiceCirculation, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjectsJACC, 1985